63
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis

, , , , , & show all
Pages 259-264 | Published online: 02 Dec 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

George A Karpouzas, Viet L Bui, Nicoletta Ronda, Ivana Hollan & Sarah R Ormseth. (2021) Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: a review of evidence and mechanistic insights. Expert Review of Clinical Immunology 17:4, pages 355-374.
Read now
Maurizio Benucci, Francesca Bandinelli, Arianna Damiani, Francesca Li Gobbi, Maria Infantino, Valentina Grossi & Mariangela Manfredi. (2018) Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis. Journal of Inflammation Research 11, pages 247-252.
Read now

Articles from other publishers (8)

Andrea Giachi, Massimo Cugno & Roberta Gualtierotti. (2022) Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis. Frontiers in Cardiovascular Medicine 9.
Crossref
Alexandru Caraba, Flavia Corina Babalic, Andreea Munteanu & Otilia Tomulescu. 2022. Rheumatoid Arthritis. Rheumatoid Arthritis.
Daniel W. Trott & Paul J. Fadel. (2019) Inflammation as a mediator of arterial ageing. Experimental Physiology 104:10, pages 1455-1471.
Crossref
Alexandre Virone, Jean-Philippe Bastard, Soraya Fellahi, Jacqueline Capeau, Stéphanie Rouanet, Jean Sibilia, Philippe Ravaud, Francis Berenbaum, Jacques-Eric Gottenberg & Jérémie Sellam. (2019) Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis. RMD Open 5:2, pages e000897.
Crossref
William F. C. Rigby, Kathy Lampl, Jason M. Low & Daniel E. Furst. (2017) Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs. International Journal of Rheumatology 2017, pages 1-15.
Crossref
Durga Prasanna Misra & Sajjan N. Shenoy. (2016) Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatology International 37:1, pages 151-167.
Crossref
Jon T. Giles. (2016) Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?. Current Rheumatology Reports 18:5.
Crossref
Daniel FJ Ketelhuth & Göran K Hansson. (2015) Modulation of Autoimmunity and Atherosclerosis – Common Targets and Promising Translational Approaches Against Disease –. Circulation Journal 79:5, pages 924-933.
Crossref